# PT-141 nasal spray: does it work? · PepVault guides

Source: https://pepvault.app/guides/pt-141-nasal-spray

Last updated: 2026-11-20

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Guides](https://pepvault.app/guides) [The science](https://pepvault.app/guides#science)

# PT-141 nasal spray: does it work?

Reviewed November 2026 17 sources [Published by PepVault](https://pepvault.app/guides/how-we-research)

PT-141 nasal spray worked in early trials but absorbed unevenly. The nasal studies by species, the FDA's 2007 blood-pressure concern, and why it became a shot.

- **Last reviewed:** Nov 20, 2026
- **Sources:** 17
- **Questions:** 5
- **Compounds:** 2

## The short answer

Yes, the nose absorbs PT-141 (bremelanotide), but unevenly. In its developer's nasal trials, sprays of more than 7 mg produced erections in men, and 20 mg raised desire in a small study of women. Blood levels varied widely from person to person, the FDA named blood pressure rises its greatest safety concern in 2007, and the drug was rebuilt as an injection. No nasal form is FDA-approved.

Every number checked at its primary source · Nov 20, 2026 · [17 sources](https://pepvault.app/guides/pt-141-nasal-spray#sources) · [How we research](https://pepvault.app/guides/how-we-research)

**Evidence:** Nasal route: phase 1 and 2 trials in men (one large at-home program never published in a journal), one 18-woman crossover study and animal work. The only approved form is the injection, tested in phase 3.

## Does the nose absorb PT-141?

PT-141 was born as a nasal spray. Palatin Technologies, the company that made it, developed it as a single spray in one nostril[13](https://pepvault.app/guides/pt-141-nasal-spray#source-13), though its early trials in men also tested injections[2](https://pepvault.app/guides/pt-141-nasal-spray#source-2). In healthy men the spray reached its peak in the blood at about 30 minutes, blood levels rose with the dose, and the half-life (the time for the level to fall by half) was 1.85 to 2.09 hours[1](https://pepvault.app/guides/pt-141-nasal-spray#source-1).

The catch is how much gets in. Bioavailability is the share of a dose that reaches the bloodstream. Injected under the skin, the approved form delivers about 100%[16](https://pepvault.app/guides/pt-141-nasal-spray#source-16). A 20 mg nasal dose gave about the same exposure as 1 to 2 times the 1.75 mg injection[7](https://pepvault.app/guides/pt-141-nasal-spray#source-7). Our arithmetic from those two numbers: roughly 9 to 18% of a sprayed dose reached the blood, compared with the shot.

| Measure | Nasal spray (trials only) | Injection under the skin (Vyleesi) |
| --- | --- | --- |
| Doses tested | Up to 20 mg in men and women[1](https://pepvault.app/guides/pt-141-nasal-spray#source-1) [4](https://pepvault.app/guides/pt-141-nasal-spray#source-4) [7](https://pepvault.app/guides/pt-141-nasal-spray#source-7) | 1.75 mg, the label's dose[16](https://pepvault.app/guides/pt-141-nasal-spray#source-16) |
| Peak in the blood | About 30 minutes[1](https://pepvault.app/guides/pt-141-nasal-spray#source-1) | About 1 hour[16](https://pepvault.app/guides/pt-141-nasal-spray#source-16) |
| Half-life | 1.85 to 2.09 hours[1](https://pepvault.app/guides/pt-141-nasal-spray#source-1) | 2.7 hours (1.9 to 4.0)[16](https://pepvault.app/guides/pt-141-nasal-spray#source-16) |
| Share reaching the blood | About 9 to 18% of the dose, by our arithmetic[7](https://pepvault.app/guides/pt-141-nasal-spray#source-7) [16](https://pepvault.app/guides/pt-141-nasal-spray#source-16) | About 100%[16](https://pepvault.app/guides/pt-141-nasal-spray#source-16) |
| From one person to the next | Wide variation in blood levels[8](https://pepvault.app/guides/pt-141-nasal-spray#source-8) [14](https://pepvault.app/guides/pt-141-nasal-spray#source-14) | Tighter, more predictable[8](https://pepvault.app/guides/pt-141-nasal-spray#source-8) [14](https://pepvault.app/guides/pt-141-nasal-spray#source-14) |
| FDA status | Never approved; development stopped[14](https://pepvault.app/guides/pt-141-nasal-spray#source-14) [17](https://pepvault.app/guides/pt-141-nasal-spray#source-17) | Approved June 2019[17](https://pepvault.app/guides/pt-141-nasal-spray#source-17) |

So the route works in the narrow sense: the peptide crosses the lining of the nose and does something. The trouble was never whether it gets in, but how much, and how differently from one person to the next.

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

PepVault records each compound's route, nasal spray or injection, and logs an as-needed compound when you take it, with no missed-dose marks. Nausea or flushing can go on the Side effects page against that day.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## What did the nasal trials find?

Here is every nasal study we could find at a primary source, grouped by species, with the injection studies in men and the animal work beside them for comparison.

| Who | Route and study dose | What it found |
| --- | --- | --- |
| Rats and monkeys[10](https://pepvault.app/guides/pt-141-nasal-spray#source-10) | Given to the animals (route not stated in the summary) | Erections in male rats and monkeys |
| Female rats[9](https://pepvault.app/guides/pt-141-nasal-spray#source-9) | Given to the animals (route not stated in the summary) | More soliciting of males, with no other change in sexual behaviour |
| Healthy men, and men with mild to moderate erectile dysfunction[1](https://pepvault.app/guides/pt-141-nasal-spray#source-1) | Nasal, single doses | Erections beat placebo above 7 mg, the first one at about 30 minutes; flushing and nausea most common |
| 19 men with erectile dysfunction[3](https://pepvault.app/guides/pt-141-nasal-spray#source-3) | Nasal 7.5 mg plus 25 mg sildenafil, crossover | The pair produced more erection than sildenafil alone |
| 342 men for whom sildenafil had failed[5](https://pepvault.app/guides/pt-141-nasal-spray#source-5) | Nasal 10 mg, at least 16 tries at home | 33.5% had a good result vs 8.5% on placebo; under an expression of concern since 2023 |
| 726 men without and 294 with diabetes (phase 2B)[13](https://pepvault.app/guides/pt-141-nasal-spray#source-13) [14](https://pepvault.app/guides/pt-141-nasal-spray#source-14) | Nasal, a range of doses, 3 months at home | Over 30% restored to normal function, in the company's words; never published in a journal |
| 18 premenopausal women with arousal disorder[4](https://pepvault.app/guides/pt-141-nasal-spray#source-4) | Nasal 20 mg, single dose, crossover | More reported moderate or high desire than on placebo; blood flow in the vagina did not change |
| Postmenopausal women (phase 2, 8 weeks at home)[15](https://pepvault.app/guides/pt-141-nasal-spray#source-15) | Nasal | Completed in 2007; no results on the registry or in a journal |
| 12 healthy men and 12 healthy women[7](https://pepvault.app/guides/pt-141-nasal-spray#source-7) | Nasal 20 mg, with or without alcohol | No interaction with alcohol; no one stopped for side effects |
| Healthy men, then men who responded poorly to Viagra[2](https://pepvault.app/guides/pt-141-nasal-spray#source-2) | Injection, 0.3 to 10 mg (4 or 6 mg in the patients) | Erections beat placebo above 1 mg in healthy men and at both doses in the patients |

The first two rows are animal studies; rats and monkeys show that the receptors respond, not what a person will feel. A 2008 bremelanotide trial in women by the author of the 342-man study was retracted in full by its journal, so it is left out of the table[6](https://pepvault.app/guides/pt-141-nasal-spray#source-6).

Read across the rows and the pattern is plain. In men, the spray reliably produced erections in the clinic, measured with RigiScan, a gauge worn on the penis, and the large at-home phase 2B trials found a benefit. In women, the nasal evidence is one 18-woman crossover study, a design where each woman takes both the drug and the placebo on different days, plus a trial whose results were never released[4](https://pepvault.app/guides/pt-141-nasal-spray#source-4) [15](https://pepvault.app/guides/pt-141-nasal-spray#source-15). The doses that worked by nose (7 to 20 mg) are several times the 1.75 mg that works by injection, which fits the low share that gets through[1](https://pepvault.app/guides/pt-141-nasal-spray#source-1) [4](https://pepvault.app/guides/pt-141-nasal-spray#source-4) [16](https://pepvault.app/guides/pt-141-nasal-spray#source-16).

## Why did Palatin stop the nasal spray?

Blood pressure. In late August 2007, after reviewing the nasal phase 1 and 2 data for erectile dysfunction, FDA reviewers "raised serious concerns about the acceptable benefit/risk ratio", "questioned the overall efficacy results", and "cited blood pressure increases as its greatest safety concern"[11](https://pepvault.app/guides/pt-141-nasal-spray#source-11). Palatin and its partner King Pharmaceuticals delayed phase 3, and King ended the partnership within a week[11](https://pepvault.app/guides/pt-141-nasal-spray#source-11) [12](https://pepvault.app/guides/pt-141-nasal-spray#source-12).

Palatin's own explanation came in its annual reports. Blood pressure rose in some patients on the spray, and that rise was "a significant factor" in ending nasal development. The company tied the blood pressure rises, and the rate of nausea and vomiting, at least partly to "variability in drug uptake with nasal administration": blood levels varied widely between patients[14](https://pepvault.app/guides/pt-141-nasal-spray#source-14). A later paper by Palatin's researchers and two academic blood pressure specialists said the same in plain terms: the spray could push some people above the level needed while leaving others with too little[8](https://pepvault.app/guides/pt-141-nasal-spray#source-8).

That is the mechanism. PT-141 switches on melanocortin-4 receptors (MC4R) in the brain, and MC4R activity can raise blood pressure[8](https://pepvault.app/guides/pt-141-nasal-spray#source-8). Through the nose, some people absorbed far more than others, so the same spray could overshoot in one person and fall short in the next[8](https://pepvault.app/guides/pt-141-nasal-spray#source-8) [14](https://pepvault.app/guides/pt-141-nasal-spray#source-14). Under the skin about 100% of the dose arrives[16](https://pepvault.app/guides/pt-141-nasal-spray#source-16), and Palatin measured much less variation from one person to the next[14](https://pepvault.app/guides/pt-141-nasal-spray#source-14).

## With this guide

### PT-141

- [PT-141: the full reference](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Melanotan II

- [Melanotan II: the full reference](https://pepvault.app/peptides/melanotan-ii)
- [Melanotan II dose guide](https://pepvault.app/lab/dosage/melanotan-ii)

### Mixing charts

- [PT-141 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pt-141-10mg)
- [Melanotan II 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/melanotan-ii-5mg)

### Studies

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
- [PT-141: desire gains over placebo held across RECONNECT subgroups](https://pepvault.app/research/pt-141-reconnect-2022)
- [PT-141: more responders than placebo at 1.75 mg on all 7 measures](https://pepvault.app/research/pt-141-althof-2019)
- [All 6 studies](https://pepvault.app/research#pt-141)
- [Melanotan II: erections in 17 of 20 men with erectile dysfunction](https://pepvault.app/research/melanotan-ii-wessells-2000)
- [Melanotan II: erections in 8 of 10 men with psychogenic ED](https://pepvault.app/research/melanotan-ii-wessells-1998)
- [Melanotan II: darker skin in 2 of 3 men in a small phase I trial](https://pepvault.app/research/melanotan-ii-dorr-1996)
- [All 5 studies](https://pepvault.app/research#melanotan-ii)

### Compared with

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)
- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan I vs Melanotan II](https://pepvault.app/peptides/compare/melanotan-i-vs-melanotan-ii)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The Skin and longevity path

- [GHK-Cu for skin and hair: what's measured](https://pepvault.app/guides/ghk-cu-skin-and-hair)
- [Melanotan 1 vs 2: what each one does](https://pepvault.app/guides/melanotan-1-vs-melanotan-2)
- [What is Cerebrolysin? The trial evidence](https://pepvault.app/guides/cerebrolysin-explained)
- [Khavinson bioregulators, explained](https://pepvault.app/guides/khavinson-bioregulators-explained)
- [SS-31 (elamipretide): what the trials show](https://pepvault.app/guides/ss-31-elamipretide)
- [MOTS-c: the mouse and human studies](https://pepvault.app/guides/mots-c-studies)
- [SS-31 vs MOTS-c: where each works and what the human data show](https://pepvault.app/guides/ss-31-vs-mots-c)
- [Are collagen peptides the same as research peptides?](https://pepvault.app/guides/collagen-vs-research-peptides)
- [GHK-Cu vs minoxidil for hair: the evidence side by side](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair)
- [GHK-Cu injection vs topical: what the studies show](https://pepvault.app/guides/ghk-cu-injection-vs-topical)
- [Thymulin vs Thymalin: what's the difference?](https://pepvault.app/guides/thymulin-vs-thymalin)
- [Semax and Selank: what the studies found](https://pepvault.app/guides/semax-and-selank)
- [PT-141 (bremelanotide) for women and men: what the trials measured](https://pepvault.app/guides/pt-141-bremelanotide)
- [How to reconstitute NAD+, and how often the studies gave it](https://pepvault.app/guides/nad-plus-mixing-and-how-often)
- [The FDA peptide panel explained: both meetings and what each vote means](https://pepvault.app/guides/fda-peptide-panel-explained)
- [Low-dose naltrexone (LDN): what it's used for and what the trials show](https://pepvault.app/guides/low-dose-naltrexone)
- [Is low-dose naltrexone (LDN) safe in pregnancy, and before trying to conceive?](https://pepvault.app/guides/ldn-and-pregnancy)
- [Do you stop low-dose naltrexone (LDN) before surgery or a colonoscopy?](https://pepvault.app/guides/ldn-before-surgery)
- [Does minoxidil cause hair loss?](https://pepvault.app/guides/minoxidil-shedding)
- [Can you take minoxidil with finasteride?](https://pepvault.app/guides/minoxidil-with-finasteride)
- [Peptides for hair growth: what the studies show](https://pepvault.app/guides/peptides-for-hair-growth)
- [Peptides for skin: what the human studies show](https://pepvault.app/guides/peptides-for-skin)
- [Do tanning peptides protect you from the sun?](https://pepvault.app/guides/tanning-peptides-and-the-sun)
- [Tretinoin vs retinol vs GHK-Cu for skin](https://pepvault.app/guides/tretinoin-vs-retinol-vs-ghk-cu)
- [Epitalon and telomeres: what was measured](https://pepvault.app/guides/epitalon-and-telomeres)
- [Dihexa: what is known, and what is not](https://pepvault.app/guides/dihexa-what-is-known)
- [Does Pinealon help sleep, and why does it make some people sleepy?](https://pepvault.app/guides/pinealon-and-sleep)
- [Selank vs oxytocin for anxiety: what the trials found](https://pepvault.app/guides/selank-vs-oxytocin-for-anxiety)
- [Oxytocin nasal spray: what it is used for](https://pepvault.app/guides/oxytocin-nasal-spray)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Bioavailability](https://pepvault.app/glossary/bioavailability)
- [Placebo](https://pepvault.app/glossary/placebo)

## Did the injection fix the blood pressure problem?

It made the effect small and predictable; it did not remove it. In a company phase 1 study of repeated injections, mean blood pressure did not differ from placebo, and no one stopped under the study's blood pressure rules[14](https://pepvault.app/guides/pt-141-nasal-spray#source-14). Then a phase 2 trial in 397 premenopausal women wore 24-hour blood pressure monitors at three injected doses[8](https://pepvault.app/guides/pt-141-nasal-spray#source-8).

| Measure | Injected 1.25 mg | Injected 1.75 mg |
| --- | --- | --- |
| Rise in systolic pressure vs placebo, 0 to 4 hours after the dose | 2.4 and 3.0 mmHg on the two test days[8](https://pepvault.app/guides/pt-141-nasal-spray#source-8) | 3.1 and 3.2 mmHg on the two test days[8](https://pepvault.app/guides/pt-141-nasal-spray#source-8) |
| Fall in heart rate vs placebo | Similar in every dose group: means of 4.8 to 6.6 beats a minute over the first 8 hours[8](https://pepvault.app/guides/pt-141-nasal-spray#source-8) | 4.6 to 4.7 beats a minute, 0 to 4 hours[8](https://pepvault.app/guides/pt-141-nasal-spray#source-8) |

The peaks usually lasted less than 15 minutes. About 7% of the women were withdrawn over their blood pressure readings, in similar shares on placebo (6%) and on the drug (4 to 9%), and the size of the rise did not track the level in the blood[8](https://pepvault.app/guides/pt-141-nasal-spray#source-8). The Vyleesi label now gives the approved dose's effect: systolic pressure up by as much as 6 mmHg and diastolic by 3, peaking 2 to 4 hours after the dose, with the heart rate down by up to 5 beats a minute, usually back to baseline within 12 hours[16](https://pepvault.app/guides/pt-141-nasal-spray#source-16).

The label's own words set the limit: Vyleesi "is contraindicated in patients who have uncontrolled hypertension or known cardiovascular disease" and "is not recommended for patients at high risk for cardiovascular disease"[16](https://pepvault.app/guides/pt-141-nasal-spray#source-16). Whether a person's heart and blood pressure allow it is the prescriber's decision, made before the first dose.

**When to get help** If you have high blood pressure or heart disease, that is a conversation for the prescriber before any dose; chest pain, a severe headache or a pounding heartbeat after a dose is a reason to get medical help the same day.

## Is there an approved PT-141 nasal spray?

No. Drugs@FDA lists one bremelanotide product: Vyleesi, 1.75 mg in 0.3 mL, in a single-dose autoinjector for injection under the skin[17](https://pepvault.app/guides/pt-141-nasal-spray#source-17). Its label covers premenopausal women with acquired, generalized hypoactive sexual desire disorder and says it is not for men[16](https://pepvault.app/guides/pt-141-nasal-spray#source-16). What the trials found with that shot, and its nausea and skin-darkening rates, is in our PT-141 (bremelanotide) guide.

A nasal spray sold as PT-141 is a different product from anything the FDA reviewed: nobody has checked how much of its labelled amount reaches the blood, or how evenly. The trial numbers do not carry over either. The nasal studies used 7.5 to 20 mg in a single spray[1](https://pepvault.app/guides/pt-141-nasal-spray#source-1) [3](https://pepvault.app/guides/pt-141-nasal-spray#source-3) [4](https://pepvault.app/guides/pt-141-nasal-spray#source-4) [7](https://pepvault.app/guides/pt-141-nasal-spray#source-7), while the approved injection is 1.75 mg[16](https://pepvault.app/guides/pt-141-nasal-spray#source-16); a milligram in the nose and a milligram under the skin are not the same amount of drug in the body.

**Commonly reported:** people who have used nasal PT-141 describe effects that vary more from one dose to the next than with injections, a brief sting or runny nose after spraying, and the same flushing and nausea the trials recorded.

<!--promo-->

PepVault records each compound's route, nasal spray or injection, and logs an as-needed compound when you take it, with no missed-dose marks. Nausea or flushing can go on the Side effects page against that day. [Log it in PepVault](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-pt-141-nasal-spray-inline&mt=8)

<!--/promo-->

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-next&mt=8)

<!--/promo-->

## Sources

1. Diamond LE et al. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141 in healthy males and patients with mild-to-moderate erectile dysfunction. Int J Impot Res. 2004. [PubMed 14963471](https://pubmed.ncbi.nlm.nih.gov/14963471/)
2. Rosen RC et al. Evaluation of the safety, pharmacokinetics and pharmacodynamic effects of subcutaneously administered PT-141 in healthy male subjects and in patients with an inadequate response to Viagra. Int J Impot Res. 2004. [PubMed 14999221](https://pubmed.ncbi.nlm.nih.gov/14999221/)
3. Diamond LE et al. Co-administration of low doses of intranasal PT-141 and sildenafil to men with erectile dysfunction results in an enhanced erectile response. Urology. 2005. [PubMed 15833522](https://pubmed.ncbi.nlm.nih.gov/15833522/)
4. Diamond LE et al. An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141). J Sex Med. 2006. [PubMed 16839319](https://pubmed.ncbi.nlm.nih.gov/16839319/)
5. Safarinejad MR, Hosseini SY. Salvage of sildenafil failures with bremelanotide: a randomized, double-blind, placebo controlled study. J Urol. 2008 (expression of concern, 2023). [PubMed 18206919](https://pubmed.ncbi.nlm.nih.gov/18206919/)
6. Safarinejad MR. Evaluation of the safety and efficacy of bremelanotide in female subjects with arousal disorder. J Sex Med. 2008 (retracted). [PubMed 18179455](https://pubmed.ncbi.nlm.nih.gov/18179455/)
7. Clayton AH et al. Phase I randomized placebo-controlled, double-blind study of the safety and tolerability of bremelanotide coadministered with ethanol in healthy male and female participants. Clin Ther. 2017. [PubMed 28189361](https://pubmed.ncbi.nlm.nih.gov/28189361/)
8. White WB et al. Usefulness of ambulatory blood pressure monitoring to assess the melanocortin receptor agonist bremelanotide. J Hypertens. 2017. [PubMed 27977473](https://pubmed.ncbi.nlm.nih.gov/27977473/)
9. Pfaus JG et al. Selective facilitation of sexual solicitation in the female rat by a melanocortin receptor agonist. Proc Natl Acad Sci USA. 2004. [PubMed 15226502](https://pubmed.ncbi.nlm.nih.gov/15226502/)
10. Molinoff PB et al. PT-141: a melanocortin agonist for the treatment of sexual dysfunction. Ann N Y Acad Sci. 2003. [PubMed 12851303](https://pubmed.ncbi.nlm.nih.gov/12851303/)
11. Palatin Technologies and King Pharmaceuticals. Press release: delay of immediate plans for a phase 3 program with bremelanotide for erectile dysfunction. August 30, 2007 (SEC Form 8-K, exhibit 99). [sec.gov](https://www.sec.gov/Archives/edgar/data/911216/000108802007000039/ex99.htm)
12. Palatin Technologies. Form 8-K: termination of the bremelanotide collaboration with King Pharmaceuticals. September 6, 2007. [sec.gov](https://www.sec.gov/Archives/edgar/data/911216/000108802007000041/form8k_090607.htm)
13. Palatin Technologies. Annual report (Form 10-K) for the fiscal year ended June 30, 2007. [sec.gov](https://www.sec.gov/Archives/edgar/data/911216/000108802007000042/form10k_063007.htm)
14. Palatin Technologies. Annual report (Form 10-K) for the fiscal year ended June 30, 2009: clinical trials with intranasal formulations, subcutaneous administration. [sec.gov](https://www.sec.gov/Archives/edgar/data/911216/000108802009000050/form10k_063009.htm)
15. ClinicalTrials.gov NCT00425256: intranasal bremelanotide in women with female sexual arousal disorder, phase 2, 8 weeks at home. Palatin Technologies. [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00425256)
16. Vyleesi (bremelanotide injection) prescribing information. Cosette Pharmaceuticals. Revised October 2026 (DailyMed). [dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1d0c1b5-2f39-4bad-a6a4-0066e3ad5dcf)
17. Drugs@FDA: NDA 210557, Vyleesi (autoinjector), subcutaneous solution; original approval June 21, 2019. [accessdata.fda.gov](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210557)

<!--promo-->

Newsletter · Weekly

## The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

<!--/promo-->

## Next guide · Skin and longevity

Guide · Skin and longevity

### [How to reconstitute NAD+, and how often the studies gave it](https://pepvault.app/guides/nad-plus-mixing-and-how-often)

How to mix an NAD+ vial with bacteriostatic water, the units for 100, 500 and 1,000 mg vials, and how often the human studies of NAD+ actually gave it.

Read the next guide

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## In the library

- [PT-141 Studied range: 0.5–2 mg](https://pepvault.app/peptides/pt-141)
- [Melanotan II Studied range: 250–500 mcg](https://pepvault.app/peptides/melanotan-ii)

## Related guides

- Guide · The science

  ### [PT-141 (bremelanotide) for women and men: what the trials measured](https://pepvault.app/guides/pt-141-bremelanotide)

  Bremelanotide (PT-141, Vyleesi): what the RECONNECT trials measured in women, the label's 40% nausea rate, and the small erection studies that exist in men.

  Read the guide
- Guide · Recovery

  ### [BPC-157 oral, nasal or injected: what each route has behind it](https://pepvault.app/guides/bpc-157-oral-nasal-injected)

  Every BPC-157 study grouped by route and species: oral, injected, cream, enema and nasal. What each route has shown, and where no study exists at all.

  Read the guide
- Guide · The science

  ### [Melanotan 1 vs 2: what each one does](https://pepvault.app/guides/melanotan-1-vs-melanotan-2)

  Melanotan 1 is afamelanotide, approved as Scenesse for EPP; melanotan 2 is unapproved. What each does, what trials measured, and how moles change.

  Read the guide

## Guides

- [All guides](https://pepvault.app/guides)
- [How we research](https://pepvault.app/guides/how-we-research)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this guide

### PT-141

- [PT-141: the full reference](https://pepvault.app/peptides/pt-141)
- [PT-141 dose guide](https://pepvault.app/lab/dosage/pt-141)

### Melanotan II

- [Melanotan II: the full reference](https://pepvault.app/peptides/melanotan-ii)
- [Melanotan II dose guide](https://pepvault.app/lab/dosage/melanotan-ii)

### Mixing charts

- [PT-141 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/pt-141-10mg)
- [Melanotan II 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/melanotan-ii-5mg)

### Studies

- [PT-141: side-effect dropouts far higher than placebo in re-analysis](https://pepvault.app/research/pt-141-spielmans-2021)
- [PT-141: desire gains over placebo held across RECONNECT subgroups](https://pepvault.app/research/pt-141-reconnect-2022)
- [PT-141: more responders than placebo at 1.75 mg on all 7 measures](https://pepvault.app/research/pt-141-althof-2019)
- [All 6 studies](https://pepvault.app/research#pt-141)
- [Melanotan II: erections in 17 of 20 men with erectile dysfunction](https://pepvault.app/research/melanotan-ii-wessells-2000)
- [Melanotan II: erections in 8 of 10 men with psychogenic ED](https://pepvault.app/research/melanotan-ii-wessells-1998)
- [Melanotan II: darker skin in 2 of 3 men in a small phase I trial](https://pepvault.app/research/melanotan-ii-dorr-1996)
- [All 5 studies](https://pepvault.app/research#melanotan-ii)

### Compared with

- [PT-141 vs Melanotan II](https://pepvault.app/peptides/compare/pt-141-vs-melanotan-ii)
- [PT-141 vs Oxytocin](https://pepvault.app/peptides/compare/pt-141-vs-oxytocin)
- [PT-141 vs Setmelanotide](https://pepvault.app/peptides/compare/pt-141-vs-setmelanotide)
- [Melanotan I vs Melanotan II](https://pepvault.app/peptides/compare/melanotan-i-vs-melanotan-ii)
- [Melanotan II vs Setmelanotide](https://pepvault.app/peptides/compare/melanotan-ii-vs-setmelanotide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)

### The Skin and longevity path

- [GHK-Cu for skin and hair: what's measured](https://pepvault.app/guides/ghk-cu-skin-and-hair)
- [Melanotan 1 vs 2: what each one does](https://pepvault.app/guides/melanotan-1-vs-melanotan-2)
- [What is Cerebrolysin? The trial evidence](https://pepvault.app/guides/cerebrolysin-explained)
- [Khavinson bioregulators, explained](https://pepvault.app/guides/khavinson-bioregulators-explained)
- [SS-31 (elamipretide): what the trials show](https://pepvault.app/guides/ss-31-elamipretide)
- [MOTS-c: the mouse and human studies](https://pepvault.app/guides/mots-c-studies)
- [SS-31 vs MOTS-c: where each works and what the human data show](https://pepvault.app/guides/ss-31-vs-mots-c)
- [Are collagen peptides the same as research peptides?](https://pepvault.app/guides/collagen-vs-research-peptides)
- [GHK-Cu vs minoxidil for hair: the evidence side by side](https://pepvault.app/guides/ghk-cu-vs-minoxidil-for-hair)
- [GHK-Cu injection vs topical: what the studies show](https://pepvault.app/guides/ghk-cu-injection-vs-topical)
- [Thymulin vs Thymalin: what's the difference?](https://pepvault.app/guides/thymulin-vs-thymalin)
- [Semax and Selank: what the studies found](https://pepvault.app/guides/semax-and-selank)
- [PT-141 (bremelanotide) for women and men: what the trials measured](https://pepvault.app/guides/pt-141-bremelanotide)
- [How to reconstitute NAD+, and how often the studies gave it](https://pepvault.app/guides/nad-plus-mixing-and-how-often)
- [The FDA peptide panel explained: both meetings and what each vote means](https://pepvault.app/guides/fda-peptide-panel-explained)
- [Low-dose naltrexone (LDN): what it's used for and what the trials show](https://pepvault.app/guides/low-dose-naltrexone)
- [Is low-dose naltrexone (LDN) safe in pregnancy, and before trying to conceive?](https://pepvault.app/guides/ldn-and-pregnancy)
- [Do you stop low-dose naltrexone (LDN) before surgery or a colonoscopy?](https://pepvault.app/guides/ldn-before-surgery)
- [Does minoxidil cause hair loss?](https://pepvault.app/guides/minoxidil-shedding)
- [Can you take minoxidil with finasteride?](https://pepvault.app/guides/minoxidil-with-finasteride)
- [Peptides for hair growth: what the studies show](https://pepvault.app/guides/peptides-for-hair-growth)
- [Peptides for skin: what the human studies show](https://pepvault.app/guides/peptides-for-skin)
- [Do tanning peptides protect you from the sun?](https://pepvault.app/guides/tanning-peptides-and-the-sun)
- [Tretinoin vs retinol vs GHK-Cu for skin](https://pepvault.app/guides/tretinoin-vs-retinol-vs-ghk-cu)
- [Epitalon and telomeres: what was measured](https://pepvault.app/guides/epitalon-and-telomeres)
- [Dihexa: what is known, and what is not](https://pepvault.app/guides/dihexa-what-is-known)
- [Does Pinealon help sleep, and why does it make some people sleepy?](https://pepvault.app/guides/pinealon-and-sleep)
- [Selank vs oxytocin for anxiety: what the trials found](https://pepvault.app/guides/selank-vs-oxytocin-for-anxiety)
- [Oxytocin nasal spray: what it is used for](https://pepvault.app/guides/oxytocin-nasal-spray)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Half-life](https://pepvault.app/glossary/half-life)
- [Bioavailability](https://pepvault.app/glossary/bioavailability)
- [Placebo](https://pepvault.app/glossary/placebo)

<!--promo-->

PepVault for iPhone

## Keep your protocol in PepVault

Log every dose, track every vial, and see your protocol come together.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=guide-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
